Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage.
about
A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.Measurement of bleeding severity: a critical review.Long-term anticoagulation. Indications and management.Pulmonary embolectomy for acute massive pulmonary embolism: an analysis of 71 cases.Use of warfarin in non-rheumatic atrial fibrillation: a commentary from general practice.Anticoagulants in venous thromboembolismOral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Risk of major hemorrhage for outpatients treated with warfarin.Computer assisted anticoagulant therapy.Objectives and Design of BLEEDS: A Cohort Study to Identify New Risk Factors and Predictors for Major Bleeding during Treatment with Vitamin K Antagonists.The risks of warfarin use in the elderly.Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.The utilization of antithrombotic prophylaxis for atrial fibrillation in a geriatric rehabilitation hospital.Consensus guidelines for coordinated outpatient oral anticoagulation therapy management. Anticoagulation Guidelines Task Force.Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.Improving the outcomes of anticoagulation: an evaluation of home follow-up of warfarin initiation.Major haemorrhagic complications during oral anticoagulant therapy in a Danish population-based cohort.Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy.
P2860
Q30996878-A809954A-4B9A-4686-AC44-2D825151631CQ33360118-70833D52-E652-48BB-B8D7-4D2623F0CFEBQ33617257-D05D2D08-DA1B-4ECF-BEEE-55287E9F96D1Q33999683-2536AB24-FE11-41FA-8676-751F3CECA5BEQ34053704-D2B83599-A703-40A7-A447-B19DB4522F0AQ34167826-7C3F8F10-6FBC-4663-BF9D-E4ACBEAEC337Q34252907-D0449313-355B-4E22-B981-306551841F1CQ34751905-F83B0A6C-7054-481F-80CF-4DF948C82797Q36030508-6CE82D40-90F3-4C1E-B22E-DABE6685E85EQ36217536-2BB3C08D-3C02-4547-8133-704ABCF6F1D0Q36446904-B79BD7E2-650D-4662-8FD2-5ACB8E06278BQ37367719-CAE3C3F3-F4A1-418D-9CD7-398DF4D6F45EQ40994000-2C600659-3306-43E9-A631-508EA919D572Q41479598-57B5F025-CC12-4F1B-8648-9814A80B0635Q41741268-C5584EED-547A-4EA8-8EC9-317A3D7C3170Q42186702-A2809DA8-7C6E-42FF-936D-797397EA11BAQ44981847-893ACE48-6F7A-4CA8-B317-94874DFF64E7Q50561332-32071065-EA4A-4050-BC44-E614A29F00CAQ51136199-D38D33D7-25B9-40B3-A081-31B6AE5D2866
P2860
Duration of warfarin anticoagulant therapy and the probabilities of recurrent thromboembolism and hemorrhage.
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@en
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@nl
type
label
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@en
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@nl
prefLabel
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@en
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@nl
P2093
P1476
Duration of warfarin anticoagu ...... hromboembolism and hemorrhage.
@en
P2093
P304
P356
10.1016/0002-9343(86)90260-3
P407
P577
1986-08-01T00:00:00Z